您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > Gabapentin-d4
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Gabapentin-d4
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Gabapentin-d4图片
规格:98%
分子量:175.3
包装与价格:
包装价格(元)
500ug电议
1mg电议

产品介绍
An internal standard for the quantification of gabapentin
货号:ajcx22542
CAS:1185039-20-6
分子式:C9H13D4NO2
分子量:175.3
溶解度:PBS (pH 7.2): 10 mg/ml
纯度:98%
存储:Store at -20°C
库存:现货

Background:

Gabapentin-d4is intended for use as an internal standard for the quantification of gabapentin by GC- or LC-MS. Gabapentin is a γ-aminobutyric acid (GABA) analogue that acts as an anticonvulsant.1,2,3It does not bind to GABA receptors, does not influence neural uptake of GABA, and does not inhibit the GABA-metabolizing enzyme, GABA transaminase.4,5Unlike GABA, which does not pass through the blood-brain barrier, gabapentin penetrates into the central nervous system and binds to the α2δ-type voltage-gated calcium channels. Formulations containing gabapentin have been used to treat neuropathic pain caused by complex regional pain syndrome type one, cancer, and HIV as well as to control dysesthesias in patients with multiple sclerosis.1,2,3


1.van de Vusse, A.C., Stonmp-van de Berg, S.G.M., Kessels, A.H.F., et al.Randomised controlled trial of gabapentin in complex regional pain syndrome type I [ISRCTN84121379]BMC Neurol.4(13)(2004) 2.Hahn, K., Arendt, G., Braun, J.S., et al.A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathiesJ. Neurol.251(10)1260-1266(2004) 3.Caraceni, A., Zecca, E., Bonezzi, C., et al.Gabapentin for neuropathic cancer pain: A randomized controlled trial from the gabapentin cancer pain study groupJ. Clin. Oncol.22(14)2909-2917(2004) 4.Gee, N.S., Brown, J.P., Dissanayake, V.U.K., et al.The novel anticonvulsant drug, gabapentin (neurontin), binds to the α2δ subunit of a calcium channelJ. Biol. Chem.271(10)5768-5776(1996) 5.Goa, K.L., and Sorkin, E.M.Gabapentin. A review of its pharmacological properties and clinical potential in epilepsyDrugs46(3)409-427(1993)